Neisseria meningitidis causes severe invasive meningococcal diseases (IMDs) in humans including meningitis and septicemia, responsible for serious clinical conditions and leading to life-long disabilities and death. Serogroup B dominates IMDs burden in Italy, accounting for over 60% of total cases. On January 2013 the European Medicine Agency (EMA) licensed the first serogroup B meningococcal (Men B) vaccine in Europe. A number of European countries and Regions have introduced the new Men B vaccine in their immunization schedule, including Italy. In this paper we present the state of art, related critical issues and future perspectives of Men B vaccine introduction in Italy, in the context of the most recent available epidemiological data. ...
Abstract The incidence of reported meningococcal disease in Italy is among the lowest in Europe. Th...
AbstractNeisseria meningitidis group B (MenB) is a leading cause of meningitis and sepsis. A new vac...
The incidence of invasive meningococcal disease (IMD) In Italy is among the lowest in Europe. Mening...
Neisseria meningitidis causes severe invasive meningococcal diseases (IMDs) in humans including meni...
In January 2013 a novel type of multicomponent protein-based vaccine against group B meningococcal d...
In Italy, the meningococcal C conjugate vaccine (MenC) has been offered in most regions since 2009-2...
<div><p>Introduction</p><p>In January 2013 a novel type of multicomponent protein-based vaccine agai...
Immunisation against meningococcal meningitis has a long history, which has passed through several p...
Introduction. Invasive meningococcal disease (IMD) is one of the most severe vaccine-preventable dis...
INTRODUCTION:In January 2013 a novel type of multicomponent protein-based vaccine against group B me...
Introduction. Invasive meningococcal disease (IMD) is one of the most severe vaccine-preventable dis...
In Italy, the meningococcal C conjugate vaccine (MenC) has been offered in most regions since 2009-2...
Background. In Italy one third of bacterial meningitis are caused by Neisseria meningitidis. In Marc...
Meningococcal disease is an acute, severe bacterial infection caused by Neisseria meningitidis. The ...
Background Typing of Neisseria meningitidis isolates is crucial for the surveillance of invasive men...
Abstract The incidence of reported meningococcal disease in Italy is among the lowest in Europe. Th...
AbstractNeisseria meningitidis group B (MenB) is a leading cause of meningitis and sepsis. A new vac...
The incidence of invasive meningococcal disease (IMD) In Italy is among the lowest in Europe. Mening...
Neisseria meningitidis causes severe invasive meningococcal diseases (IMDs) in humans including meni...
In January 2013 a novel type of multicomponent protein-based vaccine against group B meningococcal d...
In Italy, the meningococcal C conjugate vaccine (MenC) has been offered in most regions since 2009-2...
<div><p>Introduction</p><p>In January 2013 a novel type of multicomponent protein-based vaccine agai...
Immunisation against meningococcal meningitis has a long history, which has passed through several p...
Introduction. Invasive meningococcal disease (IMD) is one of the most severe vaccine-preventable dis...
INTRODUCTION:In January 2013 a novel type of multicomponent protein-based vaccine against group B me...
Introduction. Invasive meningococcal disease (IMD) is one of the most severe vaccine-preventable dis...
In Italy, the meningococcal C conjugate vaccine (MenC) has been offered in most regions since 2009-2...
Background. In Italy one third of bacterial meningitis are caused by Neisseria meningitidis. In Marc...
Meningococcal disease is an acute, severe bacterial infection caused by Neisseria meningitidis. The ...
Background Typing of Neisseria meningitidis isolates is crucial for the surveillance of invasive men...
Abstract The incidence of reported meningococcal disease in Italy is among the lowest in Europe. Th...
AbstractNeisseria meningitidis group B (MenB) is a leading cause of meningitis and sepsis. A new vac...
The incidence of invasive meningococcal disease (IMD) In Italy is among the lowest in Europe. Mening...